semaglutide+glp+1 Novo Nordisk Expands GLP-1 Access Through Telehealth Providers Semaglutide Injection for Seniors With

Now, researchers are analyzing the data to see how GLP-1 drugs affect the risk of heart, kidney, and liver disease for people with type 1 diabetes

Curr Opin Endocrinol Diabetes Obes 32(1): 3443

The findings, which were presented at the 61st ERA Congress Friday, suggest that receiving a weekly injection of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may help prevent complications like chronic kidney disease and end-stage renal disease that often occur alongside obesity

Those with significant insulin resistance may require combination therapy rather than GLP-1 monotherapy

It is also a good fit if you want a printable GLP-1 diet plan free download before deciding whether a full plan would help